31 October 2023
Quadrise Plc
("Quadrise" or the "Company")
Morocco Project Update
Quadrise Plc (AIM: QED), the supplier of innovative energy solutions for a cleaner planet, provides an update on its fuel trial in Morocco.
The industrial demonstration test (the "Trial") at the client site in Morocco is progressing well, with the replacement pump installed, commissioned and performing as designed. With final combustion optimisation tests now jointly planned for MSAR® and bioMSAR™, the Company anticipates that the Trial will conclude during November.
Quadrise will provide an update with regard to the results of the Trial once completed, and currently anticipates being able to do so prior to the Company's annual general meeting on 27 November 2023.
For additional information, please contact:
| Quadrise Plc | | +44 (0)20 7031 7321 |
| Andy Morrison, Chairman Jason Miles, Chief Executive Officer | | |
| | | |
| Nominated Adviser | | |
| Cavendish Capital Markets Limited | | +44 (0)20 7220 0500 |
| Ben Jeynes | | |
| Katy Birkin | | |
| Joint Brokers Shore Capital Stockbrokers Limited | |
+44 (0)20 7408 4090 |
| Toby Gibbs, Rachel Goldstein (Corporate Advisory) | | |
| Fiona Conroy (Corporate Broking) | | |
|
|
|
|
| VSA Capital Limited Andrew Raca (Corporate Finance) Andrew Monk (Corporate Broking) | | +44 (0)20 3005 5000 |
| | | |
| Public & Investor Relations |
|
|
| Vigo Consulting Patrick D'Ancona Finlay Thomson | | +44 (0)20 7390 0230 |
About Quadrise
Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.
Learn more at: www.quadrise.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
